Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform.
0 ratings in the last 12 months
O gráfico de cotação considera todos os eventos passados como dividendos, splits e etc.
5 anos
% Total
5 anos
Retorno Anual
Um comparativo de Cotação vs Indicator
Esse gráfico demonstra a liquidez da ação ao longo do tempo.
Atenção: Os valores acima estão em USD (Dólar americano) e na escala de milhões—10.000 equivalem à 10 bilhões. P na tabela significa Prejuízo.